Levofloxacin Injection, Solution
Product Images NDC 55150-244

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 55150-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)

A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 750 mg' showing plasma concentration (mcg/mL) on the y-axis and time (hours) on the x-axis. Two data series are presented: one for 750 mg tablet administered orally (p.o.) and one for 750 mg intravenous infusion (i.v., 90 min). The graph compares plasma concentration changes over 36 hours for both administration routes.*

FDA Label Image

Package Label-principal Display Panel (750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose)

Levofloxacin in 5% Dextrose Injection 750 mg/150 mL sterile solution label for intravenous infusion. The label instructs to infuse over 90 minutes and keep the bag in overwrap until use. It includes storage and handling information, distributor details (AuroMedics Pharma LLC), and a barcode. The product is made in India.*

FDA Label Image

Package Label-principal Display Panel (750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose)

Levofloxacin in 5% Dextrose Injection 750 mg (5 mg/mL) in 150 mL of 5% Dextrose sterile single-use containers. The label specifies intravenous infusion with instructions to infuse over 90 minutes and to leave the bag in the overwrap until use. Distributed by AuroMedics Pharma LLC and made in India. The label includes storage, usage, and disposal instructions along with medication guide dispensing advice.*

FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)

A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg' comparing plasma concentration (mcg/mL) over time (hours) for 500 mg Levofloxacin administered orally as a tablet and intravenously. Two curves are shown: one with circular markers representing oral tablets and one with triangular markers for intravenous administration, depicting changes in plasma concentration over 36 hours.*

FDA Label Image

Package Label-principal Display Panel (250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection, 250 mg Levofloxacin (5 mg/mL) in 50 mL of 5% Dextrose. Sterile solution for intravenous infusion with instructions to infuse over 60 minutes. Manufactured in India for AuroMedics Pharma LLC. Includes barcodes, NDC 55150-243-46, and cautionary usage notes.*

FDA Label Image

Package Label-principal Display Panel (250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose)

Levofloxacin in 5% Dextrose Injection 250 mg/50 mL intravenous solution label featuring directions for infusion over 60 minutes. The label includes storage instructions and a note for pharmacists to dispense the medication guide. Distributed by AuroMedics Pharma LLC, it is a sterile, single-use container made in India.*

FDA Label Image

Package Label-principal Display Panel (250 mg Levofloxacin (5 mg / mL) in 50 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection, 250 mg Levofloxacin (5 mg/mL) in 50 mL of 5% Dextrose for intravenous infusion. The label includes dosing instructions to infuse over 60 minutes and storage conditions. Distributed by AuroMedics Pharma LLC, made in India. Contains a barcode and recycle symbol.*

FDA Label Image

Package Label-principal Display Panel (500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection 500 mg/100 mL intravenous solution. The label indicates the product is sterile and for intravenous infusion over 60 minutes. It includes storage instructions and manufacturer details: AuroMedics Pharma LLC, E. Windsor, NJ, code TS/DRUGS/01/2013/LVP.*

FDA Label Image

Package Label-principal Display Panel (500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection, 500 mg per 100 mL intravenous solution. The label includes dosing instructions to infuse over 60 minutes and advises pharmacists to dispense the Medication Guide. Distributed by AuroMedics Pharma LLC, made in India, and marked sterile with NDC 55150-244-47.*

FDA Label Image

Package Label-principal Display Panel (500 mg Levofloxacin (5 mg / mL) in 100 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection 500 mg/100 mL intravenous solution. The label highlights infusion instructions and pharmacist dispensing guidance. It provides drug concentration, storage conditions, and manufacturing details, including distribution by AuroMedics Pharma LLC and manufacturing in India. The packaging is for single-use 100 mL sterile containers.*

FDA Label Image

Package Label-principal Display Panel (750 mg Levofloxacin (5 mg / mL) in 150 mL of 5% Dextrose)

Label for Levofloxacin in 5% Dextrose Injection, 750 mg/150 mL intravenous solution. The label includes dosage concentration (5 mg/mL), instructions for infusion over 90 minutes, handling cautions, and manufacturer information for AuroMedics Pharma LLC. It also features a barcode and recycling symbol.*

FDA Label Image

Chemical Structure (Levofloxacin Str)

Chemical structure of levofloxacin, showing the molecular arrangement including fluorine, carbon, oxygen, nitrogen atoms, and associated functional groups, along with a notation indicating the presence of 1/2 water of hydration (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.